Interventional Cardiology Review最新文献_第6页

Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme. 阿拉伯联合酋长国经导管主动脉瓣置换术的结果:来自新兴项目的真实世界单中心经验。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.04

Ahmad Edris, Yosef Manla, Firas Al Badarin, Khwaja Hasan, Shahrukh Hashmani, Mahmoud Traina, Dhiaedin Khiati, Amani Khalouf, Anas El Zouhbi, Emin Murat Tuzcu

{"title":"Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme.","authors":"Ahmad Edris, Yosef Manla, Firas Al Badarin, Khwaja Hasan, Shahrukh Hashmani, Mahmoud Traina, Dhiaedin Khiati, Amani Khalouf, Anas El Zouhbi, Emin Murat Tuzcu","doi":"10.15420/icr.2022.04","DOIUrl":"https://doi.org/10.15420/icr.2022.04","url":null,"abstract":"Background: Data on outcomes of transcatheter aortic valve replacement (TAVR) in the Middle East, particularly in the United Arab Emirates (UAE), are limited. Whether centres with a low volume of patients requiring the procedure can achieve similar outcomes as those reported in pivotal clinical trials remains unclear. This study evaluates procedural outcomes of patients undergoing TAVR in a newly established programme in the UAE.Methods: Procedural outcomes of consecutive patients who underwent transfemoral TAVR at a single centre in the UAE between January 2016 and November 2021 were compared with those at centres in the lowest quartile (Q1) of procedural volume in the Transcatheter Valve Therapy Registry, which covers centres in the US.Results: Among the 183 patients included in the study, the median age was 76 years (interquartile range [IQR] 71-82), and 42.1% of patients were women, with a median Society of Thoracic Surgeons predicted risk of mortality score of 4.6 (IQR 2.9-7.5). Most of the patients (93.3%) received a balloon-expandable valve. All-cause death within 30 days, stroke and major vascular complications occurred in 0.6%, 0.6% and 2.2% of patients, respectively, compared with 3.1%, 2.2% and 4% in patients treated at Q1 hospitals.Conclusion: Patients undergoing transfemoral TAVR at an emerging centre in the Middle East had favourable outcomes compared with those performed at Q1 hospitals in the US. These findings suggest that careful patient selection for TAVR is critical and may help optimise patient outcomes, especially when procedural volumes are low.","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e08"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ea/43/icr-18-e08.PMC10433106.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10052661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation? 房颤患者经皮冠状动脉介入治疗12个月后停止抗血小板治疗真的安全吗?

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.40

Balen Abdulrahman, Richard J Jabbour, Nick Curzen

{"title":"Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?","authors":"Balen Abdulrahman, Richard J Jabbour, Nick Curzen","doi":"10.15420/icr.2022.40","DOIUrl":"https://doi.org/10.15420/icr.2022.40","url":null,"abstract":"The prevalence of AF in patients with coronary artery disease is high. The guidelines from many professional groups, including the European Society of Cardiology, American College of Cardiology/American Heart Association and Heart Rhythm Society, recommend a maximum duration of 12 months of combination single antiplatelet and anticoagulation therapy in patients who undergo percutaneous coronary intervention and who have concurrent AF, followed by anticoagulation alone beyond 1 year. However, the evidence that anticoagulation alone without antiplatelet therapy adequately reduces the well-documented attritional risk of stent thrombosis after coronary stent implantation is relatively sparse, particularly given that very late stent thrombosis (>1 year from stent implantation) is the commonest type. By contrast, the elevated risk of bleeding from combined anticoagulation and antiplatelet therapy is clinically important. The aim of this review is to assess the evidence for long-term anticoagulation alone without antiplatelet therapy 1 year post-percutaneous coronary intervention in patients with AF.","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e22"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/db/13/icr-18-e22.PMC10331563.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9812934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Percutaneous Transcatheter Closure of Post-infarction Ventricular Septal Defect: An Alternative to Surgical Intervention. 经皮经导管关闭梗死后室间隔缺损:手术干预的另一种选择。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2023.01

Diarmaid Cadogan, Marwa Daghem, Mostafa Snosi, Lynne K Williams, Jonathan Weir-McCall, Patrick A Calvert, Joel P Giblett

引用次数: 0

Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension. 肾去神经:健康专业人员管理高血压的实用指南。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.38

Roland Schmieder, Michel Burnier, Cara East, Konstantinos Tsioufis, Sean Delaney

引用次数: 1

Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis. Myval:一种治疗严重主动脉瓣狭窄的新型经导管心脏瓣膜。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2020.32

Ashok Seth, Vijay Kumar, Vivudh Pratap Singh, Dhananjay Kumar, Puneet Varma, Vishal Rastogi

引用次数: 0

Artificial Intelligence - Advisory or Adversary? 人工智能——顾问还是对手?

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.22

Johny Nicolas, Nicholas L Pitaro, Birgit Vogel, Roxana Mehran

引用次数: 0

Patent Foramen Ovale-associated Stroke and COVID-19 Vaccination. 卵圆孔未闭卒中与COVID-19疫苗接种。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.27

Maja Rojko, Natasa Cernic Suligoj, Metka Zorc, Marko Noc

{"title":"Patent Foramen Ovale-associated Stroke and COVID-19 Vaccination.","authors":"Maja Rojko, Natasa Cernic Suligoj, Metka Zorc, Marko Noc","doi":"10.15420/icr.2022.27","DOIUrl":"https://doi.org/10.15420/icr.2022.27","url":null,"abstract":"Background: COVID-19 infection has been associated with paradoxical thromboembolism through a patent foramen ovale (PFO) and ischaemic stroke. Such events have not been reported after COVID-19 vaccination. The aim of the present study was to investigate PFO-associated stroke during the mass COVID-19 vaccination in Slovenia. Methods: This prospective study, conducted between 26 December 2020 and 31 March 2022, enrolled consecutive patients (≥18 years) with PFO-associated stroke referred for a percutaneous closure to a single interventional facility in Slovenia. Results: A total of 953,546 people aged between 18 and 70 years received at least one dose of a COVID-19 vaccine approved by the European Medicines Agency. Of the 28 patients presenting with PFO-associated stroke, 12 patients (42.9%) were vaccinated prior to the event, of whom nine were women and three were men, aged between 21 and 70 years. Stroke occurred within 35 days after vaccination in six patients (50%). Clinical presentation included motor dysphasia, paresis, vertigo, ataxia, paraesthesia, headache, diplopia and hemianopia. At hospital discharge, 11 patients (91.6%) had at least one residual ischaemic lesion. Conclusion: A temporal coincidence of COVID-19 vaccination and PFO-associated stroke has been described. A potential cause-effect relationship may only be hypothesised.","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e10"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5d/67/icr-18-e10.PMC10311394.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9746309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Contemporary Left Main Percutaneous Coronary Intervention: A State-of-the-art Review. 当代左主干经皮冠状动脉介入治疗:最新进展综述。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2023.02

Refai Showkathali, Radha Priya Yalamanchi

引用次数: 0

British Cardiovascular Interventional Society Consensus: a Huge Step Towards Standardised Care for Out-of-hospital Cardiac Arrest in the UK. 英国心血管介入学会共识：英国向院外心脏骤停标准化治疗迈出一大步。

IF 0.2

Interventional Cardiology Review Pub Date : 2022-11-10 eCollection Date: 2022-01-01 DOI: 10.15420/icr.2022.25

Marko Noc, Roxana Mehran

引用次数: 0

Percutaneous Coronary Intervention in Anomalous Right Coronary Artery: Ready to Implement in Clinical Routine? 异常右冠状动脉的经皮冠状动脉介入治疗：准备好在临床常规中实施了吗？

IF 0.2